Last reviewed · How we verify

NCT06059794

Anxiety in Relation to Nausea and Vomiting in Pregnancy

Completed Last updated 20 March 2024
What this trial tests

trial testing PUQE score in Nausea Gravidarum in 102 participants. Completed in 19 March 2024.

Timeline
1 January 2023
Primary endpoint
1 March 2024
19 March 2024

Quick facts

Lead sponsorAin Shams Maternity Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment102
Start date1 January 2023
Primary completion1 March 2024
Estimated completion19 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams Maternity Hospital

Who can join

Adults 18 to 40, female only, with Nausea Gravidarum or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn more about the relation between anxiety (assessed by GAD-7 questionnaire) and the nausea and vomiting in pregnancy (objectively measured by PUQE score). Participants will answer 2 questionnaires: (GAD-7) for anxiety; and (PUQE score) for nausea and vomiting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing